Adrian Gerald McNicholl

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	4742	1900
h-endeksi	30	24
i10-endeksi	48	39

440

220

110

330

2009201020112012201320142015201620172018201920202021202220232024202517 73 127 144 181 298 325 417 393 382 382 434 440 390 307 290 35

Genel erişim

Tümünü görüntüle

9 makale

3 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Javier P. Gisbert (ORCID:0000-0003-2...Hospital de La Princesa; Instituto de Investigación Sanitaria Princesa (IIS-Princesa); UAM; CIBEREHDuam.es üzerinde doğrulanmış e-posta adresine sahip
Alicia C. MarinGastroenterology Unit. Hospital Universitario de La Princesa and Instituto de Investigaciónciberehd.org üzerinde doğrulanmış e-posta adresine sahip
Xavier CalvetCorporació Sanitària Universitària Parc Taulí. Universitat Autònoma de Barcelonatauli.cat üzerinde doğrulanmış e-posta adresine sahip
Fernando GomollonProfesor Titular, Universidad de Zaragozaunizar.es üzerinde doğrulanmış e-posta adresine sahip
Luis Bujanda (ORCID 0000-0002-435...Catedrático de Medicina. Instituto Biodonostia. CIBERehd. UPV/EHUosakidetza.eus üzerinde doğrulanmış e-posta adresine sahip
Emili Gené TousServei d'Urgències Parc Tauli Sabadell Hospital Universitari. Universitat Internacional de Catalunyauic.es üzerinde doğrulanmış e-posta adresine sahip
Luis Rodrigo. (ORCID: 0000-0003-171...Universidad de Oviedouniovi.es üzerinde doğrulanmış e-posta adresine sahip
Angel LanasUniversity of Zaragoza. University Clinic Hospital. IIS Aragón. Ciberehdunizar.es üzerinde doğrulanmış e-posta adresine sahip
Alfredo J Lucendo (ORCID:0000-0003...Aparato Digestivo. Hospital General de Tomelloso. Servicio de Salud de Castilla La Mancha. CIBERehdsescam.jccm.es üzerinde doğrulanmış e-posta adresine sahip
Fernando Fernández-BañaresMedico Aparato Digestivo - Hospital Universitari Mutua Terrassamutuaterrassa.es üzerinde doğrulanmış e-posta adresine sahip
Antonio GasbarriniProfessor of Gastroenterology, Catholic University, Gemelli Hospital, Rome, Italyiol.it üzerinde doğrulanmış e-posta adresine sahip
Teresa Alarconhospital de la princesahelicobacterspain.com üzerinde doğrulanmış e-posta adresine sahip
Jose Carlos Machadoi3s, IPATIMUP, Universidade do Porto, Portugalipatimup.pt üzerinde doğrulanmış e-posta adresine sahip
Marino VeneritoProfessor, Oberarzt an der Klinik für Gastroenterologie, Hepatologie und Infektiologiemed.ovgu.de üzerinde doğrulanmış e-posta adresine sahip
Limas KupcinskasProf.MD,PhD, Department of Gastroenterology, Lithuanian University of Health Scienceslsmu.lt üzerinde doğrulanmış e-posta adresine sahip
Vincent Lamymaître de stage honoraire, CHU de Charleroi - Chimay
Pilar Garcia IglesiasGastroenterologia.Hospital Universitari Igualada

Takip et

Adrian Gerald McNicholl

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd

aegastro.es üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa

Helicobacter Crohn's Disease Ulcerative Colitis


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse JP Gisbert, F Bermejo, JL Pérez-Calle, C Taxonera, I Vera, AG McNicholl, ... Inflammatory bowel diseases 15 (8), 1190-1198, 2009	435	2009
Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of Helicobacter pylori infection AG McNicholl, PM Linares, OP Nyssen, X Calvet, JP Gisbert Alimentary pharmacology & therapeutics 36 (5), 414-425, 2012	370	2012
Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease JP Gisbert, AG McNicholl Digestive and Liver Disease 41 (1), 56-66, 2009	363	2009
Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed JP Gisbert, AC Marín, AG McNicholl, M Chaparro Alimentary pharmacology & therapeutics 41 (7), 613-623, 2015	352	2015
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis JP Gisbert, PM Linares, AG McNicholl, J Maté, F Gomollón Alimentary pharmacology & therapeutics 30 (2), 126-137, 2009	294	2009
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice AG McNicholl, AC Marin, J Molina-Infante, M Castro, J Barrio, J Ducons, ... Gut 63 (2), 244-249, 2014	192	2014
IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori JP Gisbert, J Molina-Infante, J Amador, F Bermejo, L Bujanda, X Calvet, ... Gastroenterología y Hepatología 39 (10), 697-721, 2016	187*	2016
Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement JP Gisbert, F Bermejo, R Pajares, JL Perez-Calle, M Rodríguez, A Algaba, ... Inflammatory bowel diseases 15 (10), 1485-1491, 2009	179	2009
Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth … JP Gisbert, M Romano, AG Gravina, P Solís‐Muñoz, F Bermejo, ... Alimentary pharmacology & therapeutics 41 (8), 768-775, 2015	155	2015
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease JP Gisbert, AG McNicholl, F Gomollon Inflammatory bowel diseases 15 (11), 1746-1754, 2009	151	2009
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies JP Gisbert, AG McNicholl Helicobacter 22 (4), e12392, 2017	145	2017
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication) AC Marin, AG McNicholl, JP Gisbert Expert opinion on pharmacotherapy 14 (7), 843-861, 2013	135	2013
III Spanish consensus conference on Helicobacter pylori infection JP Gisbert, X Calvet, F Bermejo, D Boixeda, F Bory, L Bujanda, ... Gastroenterologia y hepatologia 36 (5), 340-374, 2013	124*	2013
Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients AG McNicholl, DS Bordin, A Lucendo, G Fadeenko, MC Fernandez, ... Clinical Gastroenterology and Hepatology 18 (1), 89-98, 2020	120	2020
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study J Molina‐Infante, AJ Lucendo, T Angueira, M Rodriguez‐Tellez, ... Alimentary pharmacology & therapeutics 41 (6), 581-589, 2015	118	2015
Sequential versus standard triple first‐line therapy for Helicobacter pylori eradication OP Nyssen, AG McNicholl, F Megraud, V Savarino, G Oderda, CA Fallone, ... Cochrane Database of Systematic Reviews, 2016	116	2016
Thiopurine methyl‐transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine‐treated inflammatory bowel disease patients Y González‐Lama, F Bermejo, A López‐Sanromán, V García‐Sánchez, ... Alimentary pharmacology & therapeutics 34 (5), 544-554, 2011	100	2011
Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori OP Nyssen, AG McNicholl, JP Gisbert Helicobacter 24 (2), e12570, 2019	88	2019
Accuracy of GastroPanel for the diagnosis of atrophic gastritis AG McNicholl, M Forné, J Barrio, C De la Coba, B González, R Rivera, ... European journal of gastroenterology & hepatology 26 (9), 941-948, 2014	77	2014
Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy JP Gisbert, J Barrio, I Modolell, J Molina-Infante, AP Aisa, ... Digestive diseases and sciences 60, 458-464, 2015	67	2015

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar